Curis Inc (NASDAQ: CRIS) has experienced a rise in its stock price by 19.48 compared to its previous closing price of 13.40. However, the company has seen a gain of 47.29% in its stock price over the last five trading days. Market Watch reported 2023-11-17 that Shares of Curis Inc. CRIS, +4.23% gained nearly 6% premarket on Friday after Truist Securities analysts initiated coverage of the cancer-focused biotech company with a buy rating.
Is It Worth Investing in Curis Inc (NASDAQ: CRIS) Right Now?
The 36-month beta value for CRIS is also noteworthy at 3.73. There are mixed opinions on the stock, with 2 analysts rating it as a “buy,” 2 rating it as “overweight,” 0 rating it as “hold,” and 0 rating it as “sell.”
The public float for CRIS is 5.88M, and at present, short sellers hold a 0.81% of that float. The average trading volume of CRIS on April 05, 2024 was 33.06K shares.
CRIS’s Market Performance
The stock of Curis Inc (CRIS) has seen a 47.29% increase in the past week, with a 55.44% rise in the past month, and a 10.64% gain in the past quarter. The volatility ratio for the week is 15.78%, and the volatility levels for the past 30 days are at 7.83% for CRIS. The simple moving average for the past 20 days is 49.12% for CRIS’s stock, with a 47.86% simple moving average for the past 200 days.
Analysts’ Opinion of CRIS
Many brokerage firms have already submitted their reports for CRIS stocks, with Truist repeating the rating for CRIS by listing it as a “Buy.” The predicted price for CRIS in the upcoming period, according to Truist is $26 based on the research report published on November 17, 2023 of the previous year 2023.
Raymond James gave a rating of “Outperform” to CRIS, setting the target price at $15 in the report published on October 13th of the previous year.
CRIS Trading at 55.51% from the 50-Day Moving Average
After a stumble in the market that brought CRIS to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -19.95% of loss for the given period.
Volatility was left at 7.83%, however, over the last 30 days, the volatility rate increased by 15.78%, as shares surge +64.04% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading +41.43% upper at present.
During the last 5 trading sessions, CRIS rose by +47.29%, which changed the moving average for the period of 200-days by -2.38% in comparison to the 20-day moving average, which settled at $11.05. In addition, Curis Inc saw 25.57% in overturn over a single year, with a tendency to cut further gains.
Stock Fundamentals for CRIS
Current profitability levels for the company are sitting at:
- -4.82 for the present operating margin
- 0.97 for the gross margin
The net margin for Curis Inc stands at -4.73. The total capital return value is set at -0.76. Equity return is now at value -143.19, with -50.40 for asset returns.
Based on Curis Inc (CRIS), the company’s capital structure generated 0.12 points at debt to capital in total, while cash flow to debt ratio is standing at -13.76. The debt to equity ratio resting at 0.14. The interest coverage ratio of the stock is -78.08.
Currently, EBITDA for the company is -48.33 million with net debt to EBITDA at 0.49. When we switch over and look at the enterprise to sales, we see a ratio of 7.03. The receivables turnover for the company is 3.59for trailing twelve months and the total asset turnover is 0.13. The liquidity ratio also appears to be rather interesting for investors as it stands at 4.51.
Conclusion
In summary, Curis Inc (CRIS) has had a better performance as of late. Analysts have bullish opinions on the stock, with some viewing it as a “buy” and others as a “hold”. It is worth mentioning that the stock is currently trading in close proximity to its 50-day moving average and its 52-week high.
